Italian clinical skincare brand Miamo will launch in the UK market this April, marking a carefully considered step in its international expansion following more than a decade of growth in Italy.
Founded in 2012, Miamo remains entirely family-managed across every pivotal role. Co-founding pharmacists Dr Elena Aceto di Capriglia and her daughter Dr Camilla D’Antonio shape the brand’s scientific vision through an enriching intergenerational dialogue, powered by advanced scientific research and a results-driven approach. Steering the overall strategic direction of the brand’s holding is co-founder, son and brother Giovanni D’Antonio, Chief Executive Officer, combining a forward-thinking vision with an uncompromising commitment to integrity.
The name ‘Miamo’ carries a value-driven meaning at the heart of the brand. Translated as ‘I love myself’, it reflects a philosophy of self-care and lifelong wellbeing, turning everyday routines into conscious acts of empowerment. Over the past decade, Miamo has built a strong reputation and loyal following in Italy, growing into a multi-million-pound business. The brand works closely with pharmacies, clinics, medical spas and skincare professionals, while continuing to invest heavily in research, development, clinical testing and patenting.
The UK has been identified as a natural next step in the brand’s expansion, reflecting both the strength of the skincare market and the growing demand among British consumers for results-driven, science-led formulations. Miamo will begin its UK rollout with an online launch in April, followed by a retail debut with a carefully selected partner planned for September, ensuring the brand enters the market in the right environment and with the appropriate level of support. Opportunities to introduce Miamo within selected spas and professional environments are also being explored.
Science sits at the core of Miamo’s identity, reflecting a family background in pharmaceuticals, chemistry and research, and guiding every aspect of formulation, testing and product development. This commitment underpins the brand’s belief that effective skincare must be rooted in rigorous scientific research. Products are formulated using advanced active ingredients, developed and tested in trusted laboratories, and supported by clinical, instrumental and dermatological studies. Each batch is also tested for nickel content to minimise the risk of allergies or intolerances, reflecting the brand’s commitment to safety and transparency.
Every product is thoughtfully designed in Italy by a highly skilled internal R&D team, guiding the process from concept to production. Research and innovation play a central role in the company’s success, with patented complexes developed through years of study and clinical experience. Among these are proprietary technologies such as ELPA25®, a patented non-photosensitising peel for very sensitive skin, originally developed by Dr Camilla following her own experience with pigmentation and melasma, and Epigenage®, created through research into epigenetic modulation of DNA transcription. These scientific foundations position Miamo at the forefront of functional, results-driven skincare.
Dr Camilla D’Antonio comments: “The UK represents an exciting and important step in our international journey. We see a strong alignment between the British consumer and our science-led approach to skincare, particularly the growing demand for transparency, clinical testing and personalised protocols. Entering the UK market allows us to share our methodology and pharmaceutical heritage with a new audience, while maintaining the same standards of research, education and efficacy that have defined Miamo in Italy for more than a decade.”
At the heart of the brand is the Miamo System, a structured methodology designed to personalise skincare routines through tailored protocols. Today, the brand offers more than 100 customisable protocols developed to address a wide range of skin conditions and concerns. Each routine follows up to a six-step sequence designed to maintain skin balance and maximise efficacy: cleansing, exfoliation, stimulation, treatment, hydration and protection.
A defining element of this approach is the science of serum layering, for which Miamo is particularly known. Rather than relying on a single product, multiple serums can be layered in a specific sequence, allowing several skin concerns to be addressed simultaneously and synergistically through compatible active ingredients. This method enables a highly personalised routine, reflecting the brand’s broader philosophy of inclusivity and tailored skincare, recognising that every individual’s skin, environment and lifestyle are different.
Within the full product range, several formulations have become standouts in Italy, particularly in anti-ageing, hydration and pigmentation-focused treatments. Hero products include the Renewal Peel Serum, an exfoliating peeling serum formulated with ELPA25®, a patented, new-generation blend of acids that stimulates cell regeneration without irritating or drying the skin. It is non-photosensitising and can be safely used even during sun exposure. In 2022, a scientific study published in the prestigious Journal of Cosmetic Dermatology confirmed the safety and efficacy of the peel, including on sensitive, dry and delicate skin.
The Age Reverse and Longevity Plus lines, supported by one granted patent and two patents pending, have achieved outstanding results, reflecting strong consumer demand for performance-driven skincare solutions designed to support long-term skin health.
Education is central to the Miamo philosophy. In Italy, the brand works with a network of more than 50 trained skincare consultants, providing consumers with personalised guidance and treatment planning, a model the company intends to introduce in the UK. Training is also a major area of investment, with specialist education provided to pharmacists, clinicians and skincare professionals, and educational materials developed by Dr Camilla used within professional training programmes.
Having a strong in-store presence remains important to the brand, allowing direct dialogue with customers and the creation of bespoke protocols based on individual skin needs. Today, Miamo products are showcased in more than 1,700 retail locations in Italy, supported by an engaged and loyal community built through ongoing education and communication.
Miamo is positioned as a premium skincare brand, focusing on ingredient quality, clinical efficacy and personalised routines rather than luxury positioning. The brand recognises that effective skincare often requires multiple products working together and pricing is structured to allow consumers to build tailored protocols suited to their individual needs.
Responsibility forms a core part of the company’s philosophy, spanning scientific, social and environmental commitments. The brand continues to invest in more sustainable formulations and packaging solutions, including refillable components where possible. Dr Elena is also actively involved in social initiatives focused on supporting young people and promoting self-confidence, reflecting the brand’s wider belief that skincare and wellbeing are closely connected.